Staphylococcus aureus-induced inflammation and bone destruction in experimental models of septic arthritis

Journal of Periodontal Research

Volumn 34, Issue 7, 1999, Pages 387-392

  Josefsson, Elisabet ^a   Tarkowski, Andrej ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Collagen adhesin; Corticosteroids; Septic arthritis; Staphylococcus aureus

Indexed keywords

ADHESIN; BACTERIAL DNA; BACTERIAL POLYSACCHARIDE; BACTERIAL TOXIN; ENTEROTOXIN; STAPHYLOCOCCUS VACCINE;

ANIMAL; ARTICLE; ARTICULAR CARTILAGE; B LYMPHOCYTE; BACTERIAL MEMBRANE; DISEASE MODEL; GENETICS; IMMUNOLOGY; INFECTIOUS ARTHRITIS; INFLAMMATION; JOINT; MICROBIOLOGY; PATHOGENICITY; PATHOPHYSIOLOGY; RODENT; SEPSIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; T LYMPHOCYTE; VIRULENCE;

ADHESINS, BACTERIAL; ANIMALS; ARTHRITIS, INFECTIOUS; B-LYMPHOCYTES; BACTERIAL CAPSULES; BACTERIAL TOXINS; CARTILAGE, ARTICULAR; DISEASE MODELS, ANIMAL; DNA, BACTERIAL; ENTEROTOXINS; INFLAMMATION; JOINTS; POLYSACCHARIDES, BACTERIAL; RODENTIA; SEPSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS; T-LYMPHOCYTES; VIRULENCE;

EID: 0033202352     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.1999.tb02271.x     Document Type: Article

References (37)

1. Esterhai JL Jr, Gelb I. Adult septic arthritis. Orthop Clin North Am 1991;22:503-514.
2. Epstein JH, Zimmermann B III, Ho G Jr. Polyarticular septic arthritis. J Rheumatol 1986;13:1105-1107.
3. Bremell T, Lange S, Svensson L et al. Outbreak of spontaneous staphylococcal arthritis and osteitis in mice. Arthritis Rheum 1990;33:1739-1744.
4. Bremell T, Lange S, Holmdahl R, Ryden C, Hansson GK, Tarkowski A. Immunopathological features of rat Staphylococcus aureus arthritis. Infect Immun 1994;62:2334-2344.
5. Bremell T, Abdelnour A, Tarkowski A. Histopathological and serological progression of experimental Staphylococcus aureus arthritis. Infect Immun 1992;60:2976-2985.
6. Abdelnour A, Bremell T, Holmdahl R, Tarkowski A. Role of T lymphocytes in experimental Staphylococcus aureus arthritis. Scand J Immunol 1994;39:403-408.
7. Zhao Y-X, Ljungdahl Å, Olsson T, Tarkowski A. In situ hybridization analysis of synovial and systemic cytokine messenger RNA expression in superantigen-mediated Staphylococcus aureus arthritis. Arthritis Rheum 1996;39: 959-967.
8. Verdrengh M, Tarkowski A. Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus. Infect Immun 1997;65:2517-2521.
9. + cells in Staphylococcus aureus septic arthritis. Clin Exp Immunol 1999;117:63-69.
10. Sakiniene E, Bremell T, Tarkowski A. Inhibition of nitric oxide synthase aggravates superantigen-mediated Staphylococcus aureus arthritis. Clin Exp Immunol 1997;110: 370-377.
11. McIness IB, Leung B, Wei X-Q, Gemmell CC, Liew FY. Septic arthritis following Staphylococcus aureus infection in mice lacking inducible nitric oxide synthase. J Immunol 1998;160:308-315.
12. Sakiniene E, Bremell T, Tarkowski A. Complement depletion aggravates Staphylococcus aureus septicemia and septic arthritis. Clin Exp Immunol 1999;115:95-102.
13. Abdelnour A, Bremell T, Holmdahl R, Tarkowski A. Clonal expansion of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin-1 producing staphylococci. Eur J Immunol 1994;24: 1161-1161.
14. Zhao Y-X, Abdelnour A, Kalland T, Tarkowski A. Overexpression of the T-cell receptor Vβ3 in transgenic mice increases the mortality during infection by enterotoxin A producing Staphylococcus aureus. Infect Immun 1995;63: 4463-4469.
15. Zhao Y-X, Abdelnour A, Holmdahl R, Tarkowski A. Mice with the xid B cell defect are less susceptible to develop Staphylococcus aureus-induced arthritis. J Immunol 1995; 155:2067-2076.
16. + T lymphocytes. Cell Immunol 1995;161:28-33.
17. Zhao Y-X, Nilsson I-M, Tarkowski A. The dual role of interferon-γ in experimental Staphylococcus aureus septicemia versus arthritis. Immunology 1998;93:80-85.
18. Hultgren O, Kopf M, Tarkowski A. Staphylococcus aureus-induced septic arthritis and septic death is decreased in IL-4 deficient mice: role of IL-4 as promoter for bacterial growth. J Immunol 1998;160:5082-5087.
19. Hultgren O, Eugster H-P, Sedgwick JD, Körner H, Tarkowski A. TNF/LTα double mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus. J Immunol 1998;161: 5937-5942.
20. Nilsson I-M, Hartford O, Foster T, Tarkowski A. Alpha-toxin and gamma-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis. Infect Immun 1999;67:1045-1049.
21. Schlievert PM. Role of superantigens in human disease. J Infect Dis 1993;167:997-1002.
22. Bremell T, Tarkowski A. Preferential induction of septic arthritis and mortality by superantigen-producing staphylococci. Infect Immun 1995;63:4185-4187.
23. Abdelnour A, Bremell T, Tarkowski A. Toxic shock syndrome toxin-1 contributes to the arthritogenicity of Staphylococcus aureus. J Infect Dis 1994;170:84-89.
24. Sheagren JN. Inflammation induced by Staphylococcus aureus. In: Gallin JI, Goldstein IM, Snyderman R. eds. Inflammation: basic principles and clinical correlates. New York: Raven Press Ltd, 1988;829-840.
25. Gotschlich EC. Immunity to extracellular bacteria. In: Paul WE, ed. Fundamental immunology. 3rd edn. New York: Raven Press. 1993;1287-1308.
26. Nilsson I-M, Lee JC, Bremell T, Ryden C, Tarkowski A. The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis. Infect Immun 1997;65:4216-4221.
27. Switalski LM, Patti JM, Butcher W, Gristina AG, Speziale P, Höök M. A collagen receptor on Staphylococcus aureus strains isolated from patients with septic arthritis mediates adhesion to cartilage. Mol Microbiol 1993;7:99-107.
28. Patti JM, Bremell T, Krajewska-Pietrasik D et al. The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect Immun 1994;62:152-161.
29. Deng G-M, Nilsson I-M, Verdrengh M, Collins LV, Tarkowski A. Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat Med 1999;5: 702-705.
30. Lee JC. The prospects for developing a vaccine against Staphylococcus aureus. Trends Microbiol 1996;4:162-166.
31. Woody MA, Krakauer T, Ulrich RG, Stiles BG. Differential immune responses to staphylococcal enterotoxin B mutations in a hydrophobic loop dominating the interface with major histocompatibility complex class II receptors. J Infect Dis 1988;177:1013-1022.
32. Nilsson I-M, Verdrengh M, Ulrich RG, Bavari S, Tarkowski A. Vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity against Staphylococcus aureus sepsis. J Infect Dis 1999;180: 1370-1373.
33. Schennings T, Heimdahl A, Coster K, Flock JI. Immunization with fibronectin binding protein from Staphylococcus aureus protects against experimental endocarditis in rats. Microb Pathog 1993;15:227-236.
34. Mamo W, Jonsson P, Flock JI et al. Vaccination against Staphylococcus aureus mastitis: immunological response of mice vaccinated with fibronectin-binding protein (FnBP-A) to challenge with S. aureus. Vaccine 1994;12:988-992.
35. Nilsson I-M, Patti JM, Bremell T. Höök M, Tarkowski A. Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death. J Clin Invest 1998;101: 2640-2649.
36. Sakiniene E. Bremell T, Tarkowski A. Corticosteroids ameliorate the course of experimental, superantigen-triggered Staphylococcus aureus arthritis. Arthritis Rheum 1996;39:1596-1605.
37. McKenney D, Pouliot KL, Wang Y et al. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science 1999;284:1523-1527.